Works matching IS 1470269X AND DT 2011 AND VI 11 AND IP 2

Results: 9

Pharmacogenetic profiling of Aurora kinase B is associated with overall survival in metastatic colorectal cancer.

Published in:

Pharmacogenomics Journal, 2011, v. 11, n. 2, p. 93, doi. 10.1038/tpj.2010.18

By:

Pohl, A;
Azuma, M;
Zhang, W;
Yang, D;
Ning, Y;
Winder, T;
Danenberg, K;
Lenz, H-J

Publication type:

Article

Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer.

Published in:

Pharmacogenomics Journal, 2011, v. 11, n. 2, p. 113, doi. 10.1038/tpj.2010.19

By:

Bergmann, T K;
Brasch-Andersen, C;
Gréen, H;
Mirza, M;
Pedersen, R S;
Nielsen, F;
Skougaard, K;
Wihl, J;
Keldsen, N;
Damkier, P;
Friberg, L E;
Peterson, C;
Vach, W;
Karlsson, M O;
Brosen, K

Publication type:

Article

Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks.

Published in:

Pharmacogenomics Journal, 2011, v. 11, n. 2, p. 81, doi. 10.1038/tpj.2010.81

By:

Roukos, D H

Publication type:

Article

Sex and CYP3A5 genotype influence total CYP3A activity: high CYP3A activity and a unique distribution of CYP3A5 variant alleles in Ethiopians.

Published in:

Pharmacogenomics Journal, 2011, v. 11, n. 2, p. 130, doi. 10.1038/tpj.2010.16

By:

Gebeyehu, E;
Engidawork, E;
Bijnsdorp, A;
Aminy, A;
Diczfalusy, U;
Aklillu, E

Publication type:

Article

Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity.

Published in:

Pharmacogenomics Journal, 2011, v. 11, n. 2, p. 121, doi. 10.1038/tpj.2010.13

By:

Leskelä, S;
Jara, C;
Leandro-García, L J;
Martínez, A;
García-Donas, J;
Hernando, S;
Hurtado, A;
Vicario, J C C;
Montero-Conde, C;
Landa, I;
López-Jiménez, E;
Cascón, A;
Milne, R L;
Robledo, M;
Rodríguez-Antona, C

Publication type:

Article

Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial.

Published in:

Pharmacogenomics Journal, 2011, v. 11, n. 2, p. 100, doi. 10.1038/tpj.2010.17

By:

Serrano, D;
Lazzeroni, M;
Zambon, C-F;
Macis, D;
Maisonneuve, P;
Johansson, H;
Guerrieri-Gonzaga, A;
Plebani, M;
Basso, D;
Gjerde, J;
Mellgren, G;
Rotmensz, N;
Decensi, A;
Bonanni, B

Publication type:

Article

BDNF Val66Met genotype and 6-month remission rates in late-life depression.

Published in:

Pharmacogenomics Journal, 2011, v. 11, n. 2, p. 146, doi. 10.1038/tpj.2010.12

By:

Taylor, W D;
McQuoid, D R;
Ashley-Koch, A;
MacFall, J R;
Bridgers, J;
Krishnan, R R;
Steffens, D C

Publication type:

Article

CYP2C9 allele frequency differences between populations of Mexican-Mestizo, Mexican-Tepehuano, and Spaniards.

Published in:

Pharmacogenomics Journal, 2011, v. 11, n. 2, p. 108, doi. 10.1038/tpj.2010.29

By:

Dorado, P;
Sosa-Macias, M G;
Peñas-LLedó, E M;
Alanis-Bañuelos, R E;
Wong, M-L;
Licinio, J;
Lares-Asseff, I;
LLerena, A

Publication type:

Article

Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project.

Published in:

Pharmacogenomics Journal, 2011, v. 11, n. 2, p. 138, doi. 10.1038/tpj.2010.14

By:

Keers, R;
Uher, R;
Huezo-Diaz, P;
Smith, R;
Jaffee, S;
Rietschel, M;
Henigsberg, N;
Kozel, D;
Mors, O;
Maier, W;
Zobel, A;
Hauser, J;
Souery, D;
Placentino, A;
Larsen, E R;
Dmitrzak-Weglarz, M;
Gupta, B;
Hoda, F;
Craig, I;
McGuffin, P

Publication type:

Article